Description
Manufacturer
BioCryst Pharmaceuticals
Usage
Oral
Medicine approved by
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Orladeyo (berotralstat)
Price range: $14,000.00 through $50,000.00
Orladeyo (berotralstat) is a medication used for the prevention of hereditary angioedema (HAE) attacks in adults and children 12 years and older.
Additional information
| Package | 28 capsules of 150 mg, 98 capsules of 150 mg |
|---|
Related products
-
Attruby (acoramidis)
$10,000.00 Select options This product has multiple variants. The options may be chosen on the product page -
Adbry / Adtralza (tralokinumab-ldrm)
$1,300.00 Select options This product has multiple variants. The options may be chosen on the product page -
Nexletol (bempedoic acid)
$400.00 Select options This product has multiple variants. The options may be chosen on the product page -
Vascepa (icosapent ethyl)
$700.00 Select options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.